Compound HLA/KIR Genotypes Influence Risk of Nasopharyngeal Carcinoma (NPC) in a Southern Chinese Cohort

Xiaojiang Gao,Minzhong Tang,Pat Martin,Yong Zeng,Mary Carrington
DOI: https://doi.org/10.1016/j.humimm.2015.07.071
IF: 2.211
2015-01-01
Human Immunology
Abstract:Southern China has recorded some of the highest incidents of NPC. The risk of NPC in China has long been associated with HLA polymorphism. In the present study, we extended the genetic analysis to HLA interactions with KIR. The study cohort included three groups from Guangxi, southern China: 1405 NPC cases, 1362 healthy individuals who are negative for EBV/IgA/VCA (a precursor for NPC onset), and 1288 healthy individuals who are positive for EBV/IgA/VCA. Four-digit HLA typing was performed using SBT. The KIR profiles (presence and absence of KIR genes) were examined using SSP. HLA-A∗11:01 was confirmed to be the major projective allele (OR = 0.58, P < 0.0001). A∗11:02, on the other hand, showed no effect on NPC risk despite the fact that the two A∗11 subtypes differ by a single amino acid at position 19, which is outside the peptide binding groove and therefore unlikely to influence peptide presentation. However, this single replacement is known to influence HLA interaction with KIR2DS4, with A∗11:02 serving as a better ligand than A∗11:01. The analysis of compound HLA/KIR genotypes showed that the presence or absence of KIR2DS4 did not change the protective effect of A∗11:01 but affected A∗11:02 association with NPC risk and EBV/IgA/VCA conversion. In the absence of KIR2DS4, A∗11:02 showed an increased risk for NPC onset as compared to EBV/IgA/VCA positive healthy individuals (OR = 5.3, P < 0.0001). On the other hand the same compound genotype showed a decreased odds ratio for EBV/IgA/VCA seroconversion (OR = 0.25, P = 0.002). In other words, in the absence of KIR2DS4, individuals having A∗11:02 are less likely to convert to EBV/IgA/VCA positivity,but among EBV/IgA/VCA positive individuals the A∗11:02+/ KIR2DS4- genotype confers an increased risk for NPC onset. HLA/KIR interaction may play an important role in NPC pathogenesis.
What problem does this paper attempt to address?